[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567722":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":39,"responsibleParty":59,"collaborators":18,"id":61,"slug":18,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":18,"enrollmentInfo":71,"targetDuration":18,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":81,"overallStatus":41,"whyStopped":18,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"VA Office of Research and Development","FED",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"E-trigger","EXPERIMENTAL","The NCCP Intervention is made up of multiple components. The investigators will start by applying the e-trigger and assessing the FIB-4 score, and then will train and educate PACT personnel on managing patients with positive triggers, including making treatment recommendations in collaboration with an inter-professional team. The e-trigger will be generated every three months.",[13],"Behavioral: E-trigger",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual care","NO_INTERVENTION","The control group will receive no additional training or education. PACTs will provide usual care.",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"BEHAVIORAL","The NCCP Intervention is multicomponent. First, the investigators will apply the e-trigger and calculate FIB-4, and second, will educate and train PACT personnel on how to deal with trigger positive patients as well as make treatment recommendations within an inter-professional team. The e-trigger will be generated every 3 months. The effectiveness of the trigger will be assessed using the outcomes previously mentioned.",[9],[25],{"name":26,"affiliation":27,"role":28},"Hashem B. El-Serag, MD MPH","Michael E. DeBakey VA Medical Center, Houston, TX","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Hashem B El-Serag, MD MPH","CONTACT","(713) 794-8640","Hashem.El-Serag@va.gov",{"name":36,"role":32,"phone":37,"phoneExt":18,"email":38},"Kyler Godwin, PhD MPH BS","(713) 440-4672","kyler.godwin@va.gov",[40],{"facility":27,"status":41,"city":42,"state":43,"zip":44,"country":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"RECRUITING","Houston","Texas","77030-4211","United States",{"type":47,"coordinates":48},"Point",[49,50],-95.36327,29.76328,{"lat":50,"lon":49},[53,55,56,57],{"name":31,"role":32,"phone":54,"phoneExt":18,"email":34},"713-794-8640",{"name":36,"role":32,"phone":37,"phoneExt":18,"email":38},{"name":26,"role":28,"phone":18,"phoneExt":18,"email":18},{"name":36,"role":58,"phone":18,"phoneExt":18,"email":18},"SUB_INVESTIGATOR",{"type":60,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100567722",false,"NCT06671886","NAFLD Clinical Care Pathway","Testing the Effectiveness of NAFLD Clinical Care Pathway in VA Primary Care","NCCP","Inclusion Criteria:\n\nPatient Aligned Care Teams (PACT) at the Michael E. DeBakey VA Medical Center\n\nExclusion Criteria:\n\n* The investigators will exclude PACTs with unstable leadership (i.e., pending departure, vacancy) at time of randomization.\n* PACTs participating in the focus groups in Aim 1 will be excluded in Aim 2 to avoid cross contamination.\n* PACTs meeting the following criteria will be excluded from randomization in Aim 2:\n\n  * PACTs who do not treat NAFLD,\n  * PACTs not located at the main hospital,\n  * PACTs with less than 100 visits within 3 months.",true,"ALL","18 Years",{"count":72,"type":73},32,"ESTIMATED","INTERVENTIONAL",[76],"NA","Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure and liver cancer. Obesity and diabetes, conditions that are very common among Veterans are the main risk factors for NAFLD. Therefore, the burden of NAFLD and its complications among Veterans is substantial. However, most VA patients with NAFLD are undiagnosed and untreated, and their care is not consistent with practice guidelines. The NAFLD Clinical Care Pathway (NCCP) intervention seeks to close this major gap in the care of Veterans by automatically identifying patients at risk of NAFLD, calculating their risk scores of having severe NAFLD, and educating the primary care providers on the diagnosis and treatment of NAFLD. This clinical trial will test the benefit of this NCCP intervention against usual care in increasing the rates of NAFLD diagnosis as well as referral to and enrollment in appropriate treatment. The study will also identify barriers and promotors of future NCCP implementation.",[79,80],"NAFLD","MASLD",[79,82,83,80],"Veterans","Primary health care","2025-11-13",{"date":86,"type":87},"2025-11-14","ACTUAL",{"date":89,"type":87},"2024-02-02",{"date":91,"type":73},"2028-11-13",{"name":5,"class":6},1]